Dr. Anthony Fauci holds up a MadSkillsDesign illustration at Congressional Hearing (2020)
3D Illustrations
Clarthins Fields
Lassa Blueprint
Zika Capsids & Antbodies
Cell Dance
Antibodies & HIV Trimer
Antibody Ships
Ebola Fields
Antibody Foosball
Germinal Center Ice
Hammer & Chisel Antibody
Antibody Racetrack
HCV Tangle
Covid Virions Contained
Spring Time
Trimer Light Bulb
Antibody Anchor
Antibody Rain
Crown Jewels
SARS-CoV-2
2D Illustrations
HIV Replication Cycle
Diverse Array of Disease-Causing Agents
A diverse array of disease-causing agents and glycan antigens are targeted by existing and developmental carbohydrate vaccines Bacteria: capsular polysaccharide repeats associated with particular species (and serotypes). Fungi: β-glucan (Candida, Cryptococcus and Aspergillus), β-mannan (Candida), common GXM motifs for serotypes A-D (Cryptococcus). Parasites: synthetic GPI motif (Plasmodium falciparum), common tyvelose-containing Ag (Trichinella), LDN(F) (Schistosoma), common LPG (Leishmania). Viruses: high mannose, GlcNAc2Man9 (HIV). Tumours: common glycan antigens associated with glycolipids (Globo H, Fucosyl GM1, LeY) and glycoproteins (TF, LeY, Tn, sTn and PSA) found on various malignant tissues.
Rift Valley Fever Virus
Relationships of Tfh Cells to Diseases
Immunodominance in Protective B cell Responses
Targets of T Cell Responses to SARS-CoV-2…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Elicitation of Highly Protective Anti-Malarial Antibodies in a Humanized Mouse Model
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
Best-In-Class Anti-Malarial Antibody Generation
COVID Natural, Vaccine & Hybrid Immunity to SARS-CoV-2 variants
Humoral and cellular immune memory to four COVID-19 vaccines
Clients
